Additional mechanisms that could explain some variability in the expression of the TOX protein might be genetic alterations including copy number variation such as amplification/deletion or translocations involving TOX, as observed in DLBCL [25] and primary central nervous system lymphoma [31]. The gene discussed is TOX; the disease is diffuse large B-cell lymphoma.